申请人:Warner-Lambert Company
公开号:US05143928A1
公开(公告)日:1992-09-01
The novel 3,5-ditertiarybutyl-4-hydroxy-phenylmethylene derivative of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents having inhibiting activity for 5-lipoxygenase, cyclooxygenase, or both.
这个句子的中文翻译是:“这种小说3,5-二叔丁基-4-羟基苯甲亚甲基衍生物是2-取代噻唑烷酮、噁唑烷酮和咪唑烷酮的抗炎药物,具有对5-脂氧合酶、环氧合酶或两者的抑制活性。”